Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

PET Helps Tailor Therapy in Limited-Stage DLBCL

drugsDecember 25, 2019

Tag: DLBCL , PET , IFRT-Zevalin

PharmaSources Customer Service